# 42023-240-01 · Methylprednisolone Acetate Injection · Par Health, USA LLC — FDA drug shortage duration tracker

For 42023-240-01 · Methylprednisolone Acetate Injection · Par Health, USA LLC, package ndc is 42023-240-01; generic name is Methylprednisolone Acetate Injection; manufacturer is Par Health, USA LLC; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01.

- **Package NDC:** 42023-240-01 _(verified: appears in the quote below)_
- **Generic name:** Methylprednisolone Acetate Injection _(verified: appears in the quote below)_
- **Manufacturer:** Par Health, USA LLC _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Unavailable _(verified: appears in the quote below)_
- **FDA note:** Estimated recovery: TBD _(verified: appears in the quote below)_
- **Initial posting date:** 06/16/2022 _(verified: appears in the quote below)_
- **Last update date:** 08/18/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 1538 _(our reading, not quoted from the source)_
- **Reason for shortage:** Demand increase for the drug _(verified: appears in its own passage below)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Rheumatology _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "06/16/2022", "package_ndc": "42023-240-01", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "800-828-9393", "availability": "Unavailable", "related_info": "Estimated recovery: TBD"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/18/2026", "therapeutic_category": [ "Rheumatology" ], "dosage_form": "Injection", "presentation": "Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)", "company_name": "Par Health, USA LLC", "shortage_reason": "Demand increase for the drug", "status": "Current"

### Status

> "update_date": "08/18/2026", "therapeutic_category": [ "Rheumatology" ], "dosage_form": "Injection", "presentation": "Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)", "company_name": "Par Health, USA LLC", "shortage_reason": "Demand increase for the drug", "status": "Current"

### Last update date

> "update_date": "08/18/2026", "therapeutic_category": [ "Rheumatology" ], "dosage_form": "Injection", "presentation": "Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)", "company_name": "Par Health, USA LLC", "shortage_reason": "Demand increase for the drug", "status": "Current"

### Reason for shortage

> "update_date": "08/18/2026", "therapeutic_category": [ "Rheumatology" ], "dosage_form": "Injection", "presentation": "Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)", "company_name": "Par Health, USA LLC", "shortage_reason": "Demand increase for the drug", "status": "Current"

### Dosage form

> "update_date": "08/18/2026", "therapeutic_category": [ "Rheumatology" ], "dosage_form": "Injection", "presentation": "Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)", "company_name": "Par Health, USA LLC", "shortage_reason": "Demand increase for the drug", "status": "Current"

### Therapeutic category

> "update_date": "08/18/2026", "therapeutic_category": [ "Rheumatology" ], "dosage_form": "Injection", "presentation": "Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)", "company_name": "Par Health, USA LLC", "shortage_reason": "Demand increase for the drug", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Par%20Health,%20USA%20LLC%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-01. Review by: 2026-09-04.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).